The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Infliximab improves signs and symptoms of psoriatic arthritis: results of the IMPACT 2 trial
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Practical Nonparametric Statistics
Groggel, D. J. (2000) · Technometrics · doi:10.1080/00401706.2000.10486067 · Cited by 11,041
Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial
Hanauer, S. B., Feagan, B. G., Lichtenstein, G. R., Mayer, L. F., Schreiber, S., Colombel, J. F., Rachmilewitz, D., Wolf, D. C., Olson, A., Bao, W., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08512-4 · Cited by 4,169
(1994) · Medical Entomology and Zoology · Cited by 4,156
American college of rheumatology preliminary definition of improvement in rheumatoid arthritis
Felson, D. T., Anderson, J. J., Boers, M., Bombardier, C., Furst, D., Goldsmith, C., Katz, L. M., Lightfoot, R., Paulus, H., Strand, V., et al. (1995) · Arthritis & Rheumatism · doi:10.1002/art.1780380602 · Cited by 2,829
Severe Psoriasis – Oral Therapy with a New Retinoid
Fredriksson, T., & Pettersson, U. (2009) · Dermatologica · doi:10.1159/000250839 · Cited by 2,718
Maini, R., St Clair, E. W., Breedveld, F., Furst, D., Kalden, J., Weisman, M., Smolen, J., Emery, P., Harriman, G., Feldmann, M., et al. (1999) · The Lancet · doi:10.1016/s0140-6736(99)05246-0 · Cited by 2,345
Maini, R. N., Breedveld, F. C., Kalden, J. R., Smolen, J. S., Davis, D., MACFARLANE, J. D., Antoni, C., Leeb, B. F., Elliott, M. J., Woody, J. N., et al. (1998) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199809)41:9<1552::aid-art5>3.0.co;2-w · Cited by 1,623
Self-citationPsoriasis causes as much disability as other major medical diseases
Rapp, S. R., Feldman, S. R., Exum, M. L., Fleischer, A. B., & Reboussin, D. M. (1999) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(99)70112-x · Cited by 1,491
Etanercept in the treatment of psoriatic arthritis and psoriasis: a randomised trial
Mease, P. J., Goffe, B. S., Metz, J., VanderStoep, A., Finck, B., & Burge, D. J. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02530-7 · Cited by 1,446
Efficacy and safety of infliximab monotherapy for plaque-type psoriasis: a randomised trial
Chaudhari, U., Romano, P., Mulcahy, L., Dooley, L., Baker, D., & Gottlieb, A. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04954-0 · Cited by 890
Self-citationEtanercept treatment of psoriatic arthritis: Safety, efficacy, and effect on disease progression
Mease, P. J., Kivitz, A. J., Burch, F. X., Siegel, E. L., Cohen, S. B., Ory, P., Salonen, D., Rubenstein, J., Sharp, J. T., & Tsuji, W. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20335 · Cited by 882
PRIMER ON THE RHEUMATIC DISEASES: PART I
(1959) · Journal of the American Medical Association · doi:10.1001/jama.1959.73010270003011 · Cited by 804
Antoni, C. E., Kavanaugh, A., Kirkham, B., Tutuncu, Z., Burmester, G. R., Schneider, U., Furst, D. E., Molitor, J., Keystone, E., Gladman, D., et al. (2005) · Arthritis & Rheumatism · doi:10.1002/art.20967 · Cited by 640
Self-citationClegg, D. O., Reda, D. J., Mejias, E., Cannon, G. W., Weisman, M. H., Taylor, T., Budiman‐Mak, E., Blackburn, W. D., Vasey, F. B., Mahowald, M. L., et al. (1996) · Arthritis & Rheumatism · doi:10.1002/art.1780391210 · Cited by 447
Kaltwasser, J. P., Nash, P., Gladman, D., Rosen, C. F., Behrens, F., Jones, P., Wollenhaupt, J., Falk, F. G., & Mease, P. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20253 · Cited by 413
The epidemiology of psoriatic arthritis in Olmsted County, Minnesota, USA, 1982-1991.
Shbeeb, M. I., Uramoto, K. M., Gibson, L. E., O’Fallon, W. M., & Gabriel, S. E. (2000) · PubMed · Cited by 392
Wold, R. T., Young, F. E., Tan, E. M., & Farr, R. S. (1968) · Science · doi:10.1126/science.161.3843.806 · Cited by 378
Methotrexate and histologic hepatic abnormalities: A meta-analysis
Whiting-O'Keefe, Q. E., Fye, K. H., & Sack, K. D. (1991) · The American Journal of Medicine · doi:10.1016/s0002-9343(05)80060-9 · Cited by 358
Husted, J. A., Gladman, D. D., Farewell, V. T., & Cook, R. J. (2001) · Arthritis & Rheumatism · doi:10.1002/1529-0131(200104)45:2<151::aid-anr168>3.0.co;2-t · Cited by 347
Wong, K., Gladman, D. D., Husted, J., Long, J. A., Farewell, V. T., & Long, J. A. (1997) · Arthritis & Rheumatism · doi:10.1002/art.1780401021 · Cited by 339
Gladman, D. D., Farewell, V. T., Wong, K., & Husted, J. (1998) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199806)41:6<1103::aid-art18>3.0.co;2-n · Cited by 314
Partsch, G., Steiner, G. E., Leeb, B. F., Dunky, A., Bröll, H., & Smolen, J. S. (1997) · PubMed · Cited by 297
Van den Bosch, F., Kruithof, E., Baeten, D., De Keyser, F., Mielants, H., & Veys, E. M. (2000) · Annals of the Rheumatic Diseases · doi:10.1136/ard.59.6.428 · Cited by 288
Comparison of disability and quality of life in rheumatoid and psoriatic arthritis.
Sokoll, K. B., & Helliwell, P. (2001) · PubMed · Cited by 252
Antoni, C., Dechant, C., Hanns‐Martin Lorenz, P. D., Wendler, J., Ogilvie, A., Lueftl, M., Kalden‐Nemeth, D., Kalden, J. R., & Manger, B. (2002) · Arthritis Care & Research · doi:10.1002/art.10671 · Cited by 177
Self-citationMethotrexate and histologic hepatic abnormalities: A meta-analysis
Whiting-O'Keefe, Q. E., Fye, K. H., & Sack, K. D. (1991) · The American Journal of Medicine · doi:10.1016/0002-9343(91)90667-m · Cited by 151
Ogilvie, A. L. J., Antoni, C., Dechant, C., Manger, B., Kalden, J. R., Schuler, G., & Lüftl, M. (2001) · British Journal of Dermatology · doi:10.1046/j.1365-2133.2001.04089.x · Cited by 141
Self-citationKruithof, E., den Bosch, F. V., Baeten, D., Herssens, A., Keyser, F. D., Mielants, H., & Veys, E. M. (2002) · Annals of the Rheumatic Diseases · doi:10.1136/ard.61.3.207 · Cited by 121
Feletar, M., Brockbank, J. E., Schentag, C. T., Lapp, V., & Gladman, D. D. (2004) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2003.006775 · Cited by 97
Efficacy of infliximab in resistant psoriatic arthritis
Salvarani, C., Cantini, F., Olivieri, I., Macchioni, P., Padula, A. A., Niccoli, L., Catanoso, M., Scocco, G. L., & Boiardi, L. (2003) · Arthritis Care & Research · doi:10.1002/art.11201 · Cited by 77
Psoriasis and Psoriatic Arthritis: An Integrated Approach
Gordon, K. B., & Ruderman, E. (2005) · Springer eBooks · doi:10.1007/b138733 · Cited by 67
An immunofluorescent method using crithidia luciliae to detect antibodies to double‐stranded DNA
Crowe, W., & Kushner, I. (1977) · Arthritis & Rheumatism · doi:10.1002/art.1780200308 · Cited by 66
Cited by
Reich, K., Nestle, F. O., Papp, K., Ortonne, J.-P., Evans, R., Guzzo, C., Li, S., Dooley, L. T., & Griffiths, C. E. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67566-6 · Cited by 1,045
Self-citationJoint AAD-NPF guidelines of care for the management and treatment of psoriasis with biologics
Menter, A., Strober, B. E., Kaplan, D. H., Kivelevitch, D., Prater, E. F., Stoff, B., Armstrong, A. W., Connor, C., Cordoro, K. M., Davis, D. M. R., et al. (2019) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2018.11.057 · Cited by 969
Self-citationMcInnes, I. B., Mease, P. J., Kirkham, B., Kavanaugh, A., Ritchlin, C. T., Rahman, P., van der Heijde, D., Landewé, R., Conaghan, P. G., Gottlieb, A. B., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(15)61134-5 · Cited by 858
Self-citationAdverse effects of biologics: a network meta-analysis and Cochrane overview
Singh, J. A., Wells, G. A., Christensen, R., Tanjong Ghogomu, E., Maxwell, L. J., MacDonald, J. K., Filippini, G., Skoetz, N., Francis, D. K., Lopes, L. C., et al. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008794.pub2 · Cited by 823
McInnes, I. B., Kavanaugh, A., Gottlieb, A. B., Puig, L., Rahman, P., Ritchlin, C., Brodmerkel, C., Li, S., Wang, Y., Mendelsohn, A. M., et al. (2013) · The Lancet · doi:10.1016/s0140-6736(13)60594-2 · Cited by 807
Self-citation
Metadata
- Authors
- Antoni, C., Krueger, G. G., de Vlam, K., Birbara, C., Beutler, A., Guzzo, C., Zhou, B., Dooley, L. T., & Kavanaugh, A.
- Venue
- Annals of the Rheumatic Diseases
- Publisher
- Elsevier BV
- Published
- 2005-08
- Volume
- 64
- Issue
- 8
- Pages
- 1150-1157
- ISSN
- 0003-4967 (ISSN-L)
- OpenAlex
- W2145778588
- Cited by
- 715
- References
- 32
- FWCI
- 29.29
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.